Traws Pharma, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2025 | 605.53 K | $1.12 M | 0.00% | 10.40% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 330.00 K | $610.50 K | 0.00% | 5.67% |
| VESTAL POINT CAPITAL, LP | 11/14/2025 | 150.00 K | $277.50 K | 0.13% | 2.58% |
| VANGUARD GROUP INC | 11/07/2025 | 87.26 K | $161.43 K | 562.41% | 1.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 43.44 K | $80.37 K | 21.60% | 0.75% |
| IKARIAN CAPITAL, LLC | 11/14/2025 | 28.49 K | $52.71 K | 0.00% | 0.49% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2025 | 22.02 K | $40.73 K | 37.07% | 0.38% |
| HRT FINANCIAL LP | 11/14/2025 | 12.57 K | $23.00 K | 100.00% | 0.22% |
| XTX TOPCO LTD | 11/14/2025 | 10.71 K | $19.81 K | 100.00% | 0.18% |
| BLACKROCK, INC. | 11/12/2025 | 9.96 K | $18.42 K | 0.00% | 0.17% |
| CITIGROUP INC | 11/10/2025 | 3.53 K | $6.53 K | 5,780.00% | 0.06% |
| MORGAN STANLEY | 11/14/2025 | 719 | $1.33 K | 0.00% | 0.01% |
| SBI SECURITIES CO., LTD. | 11/05/2025 | 162 | $300 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 102 | $189 | 8.51% | 0.00% |
| VERMILLION & WHITE WEALTH MANAGEMENT GROUP, LLC | 11/26/2025 | 96 | $178 | 0.00% | 0.00% |
| UBS GROUP AG | 11/13/2025 | 6 | $11 | -99.80% | 0.00% |
| FMR LLC | 11/13/2025 | 2 | $4 | 0.00% | 0.00% |
| ASSETMARK, INC | 11/06/2025 | 2 | $4 | 100.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| TWO SIGMA SECURITIES, LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| ALYESKA INVESTMENT GROUP, L.P. | 11/17/2025 | 0 | $0 | -100.00% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Traws Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 22 institutional investors and hedge funds held shares of Traws Pharma, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 605,531
ADAGE CAPITAL PARTNERS GP, L.L.C.: 330,000
Vestal Point Capital, LP: 150,000
VANGUARD GROUP INC: 87,259
GEODE CAPITAL MANAGEMENT, LLC: 43,440
Ikarian Capital, LLC: 28,493
22.41% of Traws Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.30 M shares in the last 24 months. This purchase volume represents approximately $2.90 M in transactions.